Clinical Research Directory
Browse clinical research sites, groups, and studies.
SIMPLIFication of Care Pathways for Patients With Rare Brain Tumors Through Artificial Intelligence
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Summary
This study focuses on rare brain tumors, which are heterogeneous entities with different morphological, biological, and clinical characteristics. Due to their rarity, many of these tumors fall under the RARECARE definition of rare tumors. The main objective of the study is to standardize care models and pathways for patients with rare brain tumors, using Artificial Intelligence (AI) and Machine Learning (ML) techniques to identify specific predictors of postoperative outcomes. The study includes both retrospective and prospective phases, with the collection of clinical, cognitive, and psychological data at various time points. Patients will undergo an early neuro-cognitive rehabilitation program using the RehaCom software, which will be conducted at home. The goal is to improve the quality of life and care for patients through a multidisciplinary and innovative approach.
Official title: SIMPLIF-AI: SIMPLIFication and Standardization of Care Pathways for Patients With Rare Brain Tumors Through Artificial Intelligence
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2025-01-27
Completion Date
2027-02
Last Updated
2026-02-19
Healthy Volunteers
No
Conditions
Interventions
RehaCom
Participants will receive a personalized neuro-cognitive rehabilitation program using the RehaCom software. Sessions will last approximately 30/40 minutes and will be held twice a week for 8 weeks. The rehabilitation will be aimed at enhancing and/or recovering cognitive functions that may have been compromised by the neurosurgical intervention.
Locations (2)
Fondazione IRCCS Istituto Neurologico Carlo Besta
Milan, PA, Italy
ASL 1 Abruzzo Avezzano-Sulmona-L'Aquila
L’Aquila, Italy